ImageneBio names Matt Robbins general counsel
PUBT · 07/07 11:01
Share
Listen to the news
- ImageneBio named Matt Robbins as general counsel, effective July 7, 2026.
- He will oversee legal, corporate governance, intellectual property, compliance as the company advances lead candidate IMG-007.
- Robbins most recently served as general counsel at Bright Peak Therapeutics, where he built the legal function at the clinical-stage biotech.
- He previously spent nearly nine years at Cooley in San Diego advising life sciences clients on corporate, securities, transactions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ImageneBio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607070700PRIMZONEFULLFEED9757744) on July 07, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved